ALTSTATION.IO

HCA Healthcare, Inc. (HCA) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price

$502.36

Change

-2.22%

Market Cap

$117.55B

Avg Volume

1.2M

Company Overview

HCA Healthcare, Inc. is a leading player in the healthcare sector, operating an extensive network of hospitals and related facilities across the United States. Their offerings include a broad range of medical services, such as emergency care, inpatient and outpatient surgery, and various specialized treatments like cardiac care and rehabilitation. Their customers range from patients needing urgent medical attention to health plans and employer groups that seek comprehensive care solutions for their members.

HCA holds a significant position as a market leader in the medical care facilities sector. They benefit from economies of scale, with over 180 hospitals and thousands of outpatient facilities, giving them a competitive edge in service delivery and cost efficiency. Key competitors include Universal Health Services and Tenet Healthcare, but HCA’s vast scale and diverse service offerings help to establish its dominance. However, the company faces challenges from growing regulatory pressures, workforce shortages, and increasing competition in outpatient care settings.

Currently, HCA Healthcare is in a growth phase, driven by increased patient volumes and strategic acquisitions that expand their geographic footprint. The company recently reported a revenue increase of 8% year-over-year for the last quarter, indicating strong operational performance. Additionally, recent expansions into telehealth services and partnerships with local health entities highlight their willingness to adapt to changing market demands and patient preferences, positioning them for continued success in a competitive landscape.

Key Financials

Market Cap

$117.55B

Revenue

$75.60B

EBITDA

$15.49B

Gross Margin

41.5%

Profit Margin

9.0%

Revenue Growth

6.7%

Total Cash

$1.04B

Total Debt

$48.35B

Free Cash Flow

$6.07B

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

17.74

Forward P/E

15.14

Beta

1.36

52-Week High

$527.55

52-Week Low

$295.00

EPS

$28.31

50-Day Avg

$482.67

200-Day Avg

$418.54

Price/Book

-19.23

Technical Analysis

HCA Healthcare, Inc. (HCA) has shown a robust upward trend over the past 52 weeks, with a significant 58.8% increase in price. The chart indicates strong support around the $350 level and notable resistance at approximately $502, where the current price sits. The stock has developed a clear ascending channel throughout the year, punctuated by higher highs and higher lows, indicating sustained bullish sentiment. Recent momentum has remained positive, as evidenced by the price maintaining above the 50-day moving average, reflecting continued buying interest. The current price of $502.36 is near the 52-week high of $501.69, suggesting that the stock is at a critical resistance level, which could either lead to a breakout or a potential pullback if it fails to sustain this level. Overall, the stock remains firmly positioned on an upward trajectory within a healthy range, providing a foundation for future gains if bullish momentum continues.

Recent News and Developments

Here are the latest news and developments for HCA Healthcare, Inc

(HCA) stock in the past week:

1. HCA Healthcare Beats Q4 Earnings Estimates, Provides Bullish 2026 Outlook and Announces Share Buyback

HCA Healthcare reported strong fourth-quarter 2025 adjusted earnings of $8.01 per share, surpassing analysts’ consensus estimates of $7.37. The company’s revenue for the quarter was up 6.7% year-over-year, reaching $19.51 billion, though this slightly missed some analyst forecasts. Following these results, HCA issued a bullish profit forecast for 2026, anticipating earnings per share between $29.10 and $31.50, and also authorized a new share repurchase program of up to $10 billion and raised its quarterly dividend to $0.78 per share.

2. Analysts Raise Price Targets on HCA Healthcare Following Strong Guidance

In response to HCA Healthcare’s robust earnings report and optimistic 2026 guidance, several analyst firms upgraded their price targets for the stock. Goldman Sachs raised its price target to $558 with a “buy” rating, and Leerink Partners increased its target to $573 with an “outperform” rating. RBC Capital also boosted its price target to $555 from $525. Argus additionally raised its price target for HCA Healthcare to $560.00. The overall analyst consensus for HCA Healthcare is currently a “Moderate Buy” or “Strong Buy” with a median price target around $518.76 to $546.00.

Market Sentiment and Analyst Recommendations

Bull Case

HCA just crushed Q4 with $8.01 EPS versus $7.37 expected, and management guided 2026 earnings to $29.10-$31.50 per share, which is massive upside from current annualized levels. Revenue growth of 6.7% is solid for a mature healthcare operator, and the company is deploying $10 billion in buybacks plus raising dividends to $0.78 quarterly, signaling confidence in cash generation. At 17.74x P/E, HCA trades below historical averages despite the guidance beat and analyst upgrades to $558-$573 targets, leaving 11-14% upside to consensus. The stock has momentum on its side with a 58.8% gain over 52 weeks and sits right at resistance, poised for a breakout if it clears $527. Management’s plan to capture $400 million in cost savings through AI and automation shows they’re not just riding volume growth but actively improving margins.

Bear Case

The ACA subsidy cliff is real and brutal: HCA expects $600-900 million in adjusted EBITDA headwinds in 2026 from a projected 30% decline in care utilization among uninsured patients losing coverage. That’s a material hit that could offset margin expansion from their efficiency initiatives. The balance sheet is levered at 48.35 billion in debt against only 1.04 billion in cash, leaving little cushion if utilization drops faster than expected or if the cost savings don’t materialize on schedule. At current levels, the stock is already priced for near-perfect execution on those $400 million savings and the 2026 guidance, so any miss gets punished hard. Healthcare policy risk is elevated with potential regulatory changes, and competitive pressure from lower-cost providers and vertical integration by insurers continues to squeeze margins across the sector.

What to Watch

Monitor HCA’s quarterly admissions and same-facility volume trends starting with Q1 2026 results to see if ACA subsidy losses are tracking the 30% decline management warned about. Watch for updates on the $400 million cost savings initiative and whether automation investments are delivering measurable margin improvement by mid-year. Track the stock’s ability to break through and hold above the $527 resistance level; failure to sustain above that risks a pullback to support around $450-475. Keep tabs on Medicare reimbursement policy changes under the new administration, as any rate cuts would directly pressure HCA’s largest revenue stream. Finally, monitor competitor earnings and same-facility growth rates to assess whether HCA’s 6.7% revenue growth is market-share gain or just industry tailwinds that could reverse.

Analyst Consensus

BUY

Based on 21 analyst opinions

Low Target

$420.00

Mean Target

$528.52

High Target

$598.00

Earnings and Financial Data

Sector

Healthcare

Industry

Medical Care Facilities

Employees

N/A

Earnings & Dividends

Next Earnings

Apr 24, 2026

EPS (Trailing)

$28.31

Dividend Yield

61.0%

Payout Ratio

10.2%

Frequently Asked Questions

Is HCA a good stock to buy?

Yes, HCA Healthcare is currently rated a BUY by analysts, with a price target of $528.52. Given its solid P/E ratio of 17.74 and robust market presence, it’s worth considering for investment.

What is HCA’s current dividend yield?

HCA Healthcare offers a remarkable dividend yield of 61.0%, which indicates a strong potential for income generation. This yield could be an attractive feature for dividend-seeking investors.

What is HCA’s price target?

The average analyst price target for HCA is $528.52, suggesting potential upside from its current price of $502.36. This provides a clear investment thesis for those looking at future gains.

What has been HCA’s stock price range over the last year?

HCA’s stock has traded between $295.00 and $527.55 over the past year. This wide range indicates volatility but also offers opportunities for strategic entry points.

What is HCA’s market capitalization?

HCA Healthcare has a market capitalization of $117.55 billion. This positions the company as a significant player in the healthcare sector, reflecting its strong operational scale and market influence.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.